Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 on the page, a minor UI/version-tracking update with no changes to study content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedUI/metadata changes include adding a 'Show glossary' option, updating the label to 'Last Update Submitted that Met QC Criteria', capitalizing 'No FEAR Act Data', and changing the revision from v3.3.4 to v3.4.0. These updates do not alter core study content, eligibility, outcomes, or locations.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision: v3.3.4 applied to the page (replacing v3.3.3).SummaryDifference0.0%

- Check52 days agoChange DetectedDifference3%

- Check73 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no visible changes to study content or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed and included a Revision: v3.3.1 tag. Updated the PubMed publication description (deletions) to reflect a new wording and Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.